- Trials with a EudraCT protocol (20)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
20 result(s) found for: Femoral Vein.
Displaying page 1 of 1.
EudraCT Number: 2005-004486-42 | Sponsor Protocol Number: CaVenT | Start Date*: 2006-01-03 |
Sponsor Name:Eastern Norway Regional Health Authority [...] | ||
Full Title: Catheter-directed Venous Thrombolysis (CaVenT) in Acute Iliofemoral Vein Thrombosis - an open Randomized, Controlled, Clinical Trial | ||
Medical condition: Acute ilio-femoral vein thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002536-94 | Sponsor Protocol Number: 1160.47 | Start Date*: 2006-03-20 |
Sponsor Name:Boehringer Ingelheim Finland Ky | ||
Full Title: A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2... | ||
Medical condition: Confirmed Venous Thromboembolism (VTE) i.e. uni or bilateral deep vein thrombosis (DVT) of the leg involving proximal veins and/or pulmonay embolism (PE) - treated with anticoagulant for 3 to 6 mo... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) AT (Completed) SE (Completed) CZ (Completed) BE (Completed) SK (Completed) GB (Completed) ES (Completed) DE (Completed) HU (Completed) PT (Completed) GR (Completed) DK (Completed) IT (Completed) BG (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005731-16 | Sponsor Protocol Number: TG-M-005 | Start Date*: 2007-01-05 |
Sponsor Name:ThromboGenics Ltd. | ||
Full Title: An Open Label Clinical Trial of Microplasmin Administered via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis | ||
Medical condition: Acute Iliofemoral Deep Vein Thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001723-12 | Sponsor Protocol Number: ARIVA_venous | Start Date*: 2020-05-28 |
Sponsor Name:Universitätsspital Zürich, Klinik für Angiologie | ||
Full Title: Aspirin® plus rivaroxaban versus rivaroxaban alone for the prevention of venous stent thrombosis in patients with post-thrombotic syndrome | ||
Medical condition: Post-thrombotic syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006014-41 | Sponsor Protocol Number: Vasovist MA-01 | Start Date*: 2008-04-14 | |||||||||||
Sponsor Name:University Heidelberg, University Hospital Mannheim | |||||||||||||
Full Title: Determination of Diagnostic Accuracy and Added Value of Vasovist®-Enhanced Peripheral MRA in Comparison to Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients with Peripheral Arte... | |||||||||||||
Medical condition: Patients suffering from PAOD stage III or stage IV (confirmed by ECCM MRA, CTA, non-selective DSA, DUS) and have an indication for the evaluation of the entire lower leg axis down to the feet (comm... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024597-19 | Sponsor Protocol Number: CV185-079 | Start Date*: 2011-06-21 | ||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | ||||||||||||||||||
Full Title: Multiple-Dose Study Apixaban in Pediatric Subjects with an Indwelling Central Venous Catheter Revised Protocol 03, to incorporate Protocol amendments 1, 3 & 4 | ||||||||||||||||||
Medical condition: Prevention of VTE in pediatric subject with a central venous cathether. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) NL (Ongoing) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004708-30 | Sponsor Protocol Number: DU176b-D-U311 | Start Date*: 2015-05-07 | |||||||||||
Sponsor Name:Daiichi Sankyo , Inc. | |||||||||||||
Full Title: A PHASE 3B, PROSPECTIVE, RANDOMIZED, OPEN-LABEL, BLIND EVALUATOR (PROBE) STUDY EVALUATING THE EFFICACY AND SAFETY OF (LMW) HEPARIN/EDOXABAN VERSUS DALTEPARIN IN VENOUS THROMBOEMBOLISM ASSOCIATED W... | |||||||||||||
Medical condition: venous thromboembolism associated with cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) BE (Completed) IT (Completed) DE (Completed) ES (Completed) AT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007947-28 | Sponsor Protocol Number: EFC10636 | Start Date*: 2008-08-27 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with placebo for the Extended Prevention of Venous Thromboembolism in Patients Having Under... | |||||||||||||
Medical condition: The subjects who will participate to this clinical trial are patients having undergone hip fracture surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001999-12 | Sponsor Protocol Number: 1160.53 | Start Date*: 2006-03-14 |
Sponsor Name:Boehringer Ingelheim Ltd. | ||
Full Title: A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute sy... | ||
Medical condition: Acute symptomatic venous thromboembolism (VTE), i.e. uni- or bilateral deep vein thrombosis (DVT) of the leg involving proximal veins, and/or pulmonary embolism (PE) confirmed by definitive objecti... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) FI (Completed) SE (Completed) DK (Completed) AT (Completed) BE (Completed) ES (Completed) HU (Completed) CZ (Completed) PT (Completed) GR (Completed) IT (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002631-86 | Sponsor Protocol Number: 1160.46 | Start Date*: 2008-10-23 | ||||||||||||||||
Sponsor Name:Boehringer Ingelheim Austia Gm.b.H | ||||||||||||||||||
Full Title: A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute sy... | ||||||||||||||||||
Medical condition: Acute symptomatic VTE VTE is defined as the composite incidence of Deep Vein Thrombosis of the leg (including the inferior caval vein) and Pulmonary Embolism. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) SK (Completed) ES (Completed) GB (Completed) NL (Completed) DK (Completed) CZ (Completed) SE (Completed) HU (Completed) FR (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-018141-20 | Sponsor Protocol Number: IN0901INT | Start Date*: 2010-06-30 | |||||||||||
Sponsor Name:LEO Pharma A/S | |||||||||||||
Full Title: Eficacia y Seguridad del Tratamiento a Largo Plazo (6 meses) con Innohep® frente a Anticoagulación con un Antagonista de la Vitamina K (Warfarina) para el Tratamiento del Tromboembolismo Venoso Agu... | |||||||||||||
Medical condition: Tromboembolismo venoso (TEV) en pacientes con cáncer activo. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) SK (Completed) CZ (Completed) AT (Completed) PT (Completed) IT (Completed) DK (Completed) GR (Completed) LV (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000981-70 | Sponsor Protocol Number: 1408143 | Start Date*: 2016-03-08 |
Sponsor Name:Centre Hospitalier Universitaire de Saint-Etienne | ||
Full Title: A multicentre, randomised, double-blind, controlled, phase IIIb study to assess the efficacy and safety of Rivaroxaban 10mg od versus Enoxaparin 4000 IU for VTE PROphylaxis in NOn Major Orthopaedic... | ||
Medical condition: Venous Thromboembolism Prophylaxis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Ongoing) ES (Completed) CZ (Completed) NL (Completed) DE (Completed) GR (Completed) PL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003085-12 | Sponsor Protocol Number: ANT-008 | Start Date*: 2022-05-10 |
Sponsor Name:Anthos Therapeutics | ||
Full Title: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding i... | ||
Medical condition: venous thromboembolism (VTE) in patients with gastrointestinal/genitourinary cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Ongoing) NO (Ongoing) IE (Ongoing) ES (Ongoing) HU (Ongoing) IT (Ongoing) NL (Ongoing) SE (Ongoing) AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003076-14 | Sponsor Protocol Number: ANT-007 | Start Date*: 2022-05-10 |
Sponsor Name:Anthos Therapeutics | ||
Full Title: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in ... | ||
Medical condition: venous thromboembolism (VTE) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Ongoing) NO (Ongoing) IE (Ongoing) ES (Ongoing) NL (Ongoing) IT (Ongoing) HU (Ongoing) SE (Ongoing) AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000417-44 | Sponsor Protocol Number: PHP-OCM-301A | Start Date*: 2016-03-31 | |||||||||||
Sponsor Name:Delcath Systems, Inc | |||||||||||||
Full Title: A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma. | |||||||||||||
Medical condition: Hepatic-Dominant Ocular Melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Prematurely Ended) AT (Prematurely Ended) BE (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007945-11 | Sponsor Protocol Number: EFC10343 | Start Date*: 2008-05-09 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fra... | |||||||||||||
Medical condition: The subjects who will participate to this clinical trial are patients undergoing Hip Fracture Surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) ES (Completed) PT (Completed) IT (Completed) CZ (Completed) GR (Completed) BG (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003812-10 | Sponsor Protocol Number: PHP-ICC-203 | Start Date*: 2017-08-29 | |||||||||||
Sponsor Name:Delcath Systems Inc. | |||||||||||||
Full Title: A Randomized, Controlled Study to Compare the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment Given Sequentially Following Cisplatin/Gemcitabine versus Cisplatin/Gemcitabine (Stand... | |||||||||||||
Medical condition: Intrahepatic cholangiocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001125-26 | Sponsor Protocol Number: ORG322 | Start Date*: 2006-08-04 |
Sponsor Name:University of Aberdeen | ||
Full Title: A randomised controlled trial of oral l-arginine supplementation on platelet and endothelial function and walking distance in patients with peripheral arterial disease | ||
Medical condition: Peripheral arterial disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003502-28 | Sponsor Protocol Number: AP-325.04 | Start Date*: 2020-02-14 | |||||||||||
Sponsor Name:Algiax Pharmaceuticals GmbH | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AP-325 in Subjects with Peripheral Post-surgical Neuropathic Pain | |||||||||||||
Medical condition: Peripheral post-surgical neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) CZ (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000442-18 | Sponsor Protocol Number: ABM/2020/1/00002 | Start Date*: 2021-09-24 | ||||||||||||||||
Sponsor Name:National Institute of Cardiology | ||||||||||||||||||
Full Title: Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial) | ||||||||||||||||||
Medical condition: Mitral regurgitation Atrial fibrilation Periprocedural anticoagulation strategy in patients treated with MitraClip implantation or Left Atrial Appendage Closure. The patients scheduled for Mitr... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.